Stay updated on Gantenerumab in Mild Alzheimer Disease Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.

Latest updates to the Gantenerumab in Mild Alzheimer Disease Clinical Trial page
- Check6 days agoChange DetectedAdded a new 2024 publication citation for Long-Term Safety of Gantenerumab in Alzheimer’s disease to the study's Publications list, listing authors Neve A et al. with the DOI; the revision tag was updated to v3.6.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRecruitment status has been updated to closed, and new user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The removal of the old 'Intervention / Treatment' heading and the update to the site revision banner (v3.6.0) reflect a reorganization and version update.SummaryDifference0.2%

- Check28 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, indicating a newer page build. This reflects an update to the page’s versioning rather than changes to the study content.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the site; the study details and navigation remain unchanged.SummaryDifference0.0%

- Check63 days agoChange DetectedThe Malmö, Sweden entry replaces Malmo, Sweden, 211 46 to reflect the proper Swedish spelling in the study locations.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page’s displayed software/version revision indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Gantenerumab in Mild Alzheimer Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.